Christopher J. Hornung

Lucigen Corp. engages in the development, manufacture, and sale of biomedical research products and services. The firm offers products for array-based analysis; cloning kits and vectors; competent cells; enzymes; in vitro transcription; next gen sequencing (NGS); nucleic acid extraction and purification; PCR and amplification; protein expression; and transposon mutagenesis. It also provides NGS and custom competent cell services. The company was founded by David Mead and Thomas W. Schoenfeld in 1998 and is headquartered in Middleton, WI.

HockeyTech Testing provides hockey testing technology and services. It offers cutting-edge technology for the hockey players. The company was founded by Jim Price in 1998 and is headquartered in Waterloo, Canada.

Sturbridge Capital LLC is an independent, SEC-registered investment advisor headquartered in Birmingham, Michigan. The firm was founded in 2011 by Salam N. Chaudhary and Chris J. Hornung. Sturbridge Capital provides attractive liquidity solutions to a broad universe of private equity investors, which includes public and private pension funds, corporations, foundations, university endowments, family offices and individuals.

Doskocil Manufacturing Co., Inc. engages in the manufacture and market of pet containment products. It produces products for dogs and puppies, cats and kittens, and for birds. The firm's products are marketed under the brands Bamboo, Booda, Dogzilla, FatCat, LeBistro and Kennel-aire. The company was founded in 1959 and is headquartered in Arlington, TX.

Pacific Cycle, Inc. manufactures bicycles and other recreational products. It markets its products under the Schwinn, Mongoose, GT, Schwinn Motor Scooters, Kustom Kruiser, Roadmaster, Pacific, Dyno, Powerlite, and Pacific Outdoors brand names. The company was founded in 1977 by Christopher Hornung and is headquartered in Madison, WI.

Quintessence Biosciences, Inc. develops and manufactures biopharmaceutical products. Its products are based on the Evade Ribonuclease Technology which allows for the engineering of human proteins (ribonucleases) for the treatment of human diseases. The company was founded by Laura L. Kiessling and Ronald T. Raines in 1999 and is headquartered in Madison, WI.